Key statistics
On Tuesday, Kyverna Therapeutics Inc (KYTX:NSQ) closed at 4.60, 4.07% above its 52-week low of 4.42, set on Oct 07, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.46 |
---|---|
High | 4.65 |
Low | 4.45 |
Bid | 4.52 |
Offer | 4.96 |
Previous close | 4.45 |
Average volume | 430.34k |
---|---|
Shares outstanding | 43.15m |
Free float | 38.49m |
P/E (TTM) | -- |
Market cap | 192.00m USD |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Oct 08 2024 21:00 BST.
More ▼
Press releases
- Kyverna Therapeutics Presents Patient Data Reinforcing Potential of KYV-101 for Treatment of Neuroinflammatory Diseases in Symposium at ECTRIMS 2024
- Kyverna Therapeutics Announces Leadership Update
- Kyverna Therapeutics to Participate in Upcoming September Investor Conferences
- Kyverna Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results
- Kyverna Therapeutics Receives U.S. FDA RMAT Designation for KYV-101 in the Treatment of Patients With Progressive Myasthenia Gravis
- Kyverna's KYV-101 Receives U.S. FDA RMAT Designation for KYV-101 in the Treatment of Patients With Refractory Stiff-Person Syndrome
More ▼